Iwamoto, F., Tanguturi, S., Desai, A., Nayak, L., Uhlmann, E., Wang, T., Lustig, R., Hertan, L., Bagley, S., Hayden, J., Laforest-Roys, C., Muzikansky, A., McCluskey, C., Chukwueke, U., McFaline-Figueroa, J. R., Lee, E., Wen, P. Y., & Reardon, D. (2022). CTIM-18. PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723). Neuro-Oncology, 24(Supplement_7), vii63–vii64. https://doi.org/10.1093/neuonc/noac209.250
Subjects:
Cancer Immunotherapy
(OpenAlex Topic)
Nanotechnology and Imaging for Cancer Therapy and Diagnosis
(OpenAlex Topic)
Engineering Bacteria for Cancer Treatment
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1093/neuonc/noac209.250
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: